Based on data from the past 90 days ending December 12, 2025, Acadia Pharmaceuticals's three largest insider shareholders are EVP And Chief Financial Officer Mark C. Schneyer (53.34K shares), Principal Accounting Officer James Kihara (25.06K shares), Director James M Daly (4.04K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Bros. Advisors Lp Baker | 39,468,841 | 05 Jun, 2023 | |
| Stephen Davis | CEO | 186,555 | 20 Aug, 2024 |
| Brendan Teehan | EVP And COO And Head Of Commercial | 62,105 | 19 Nov, 2024 |
| Srdjan R. Stankovic | President | 61,234 | 22 Nov, 2022 |
| Mark C. Schneyer | EVP And Chief Financial Officer | 53,338 | 19 Nov, 2025 |
| Austin D. Kim | EVP Andgeneral Counsel And Secretary | 46,901 | 09 Jan, 2024 |
| Daniel B Soland | 44,041 | 02 Jun, 2025 | |
| Edmund Harrigan | 35,041 | 02 Jun, 2025 | |
| Elizabeth A. Garofalo | 25,382 | 03 Sep, 2025 | |
| James Kihara | Principal Accounting Officer | 25,058 | 19 Nov, 2025 |
| Adora Ndu | 24,801 | 02 Jun, 2025 | |
| Laura Brege | 15,095 | 05 Jun, 2025 | |
| Elena Ridloff | EVP And Cfo | 10,553 | 30 Apr, 2021 |
| Michael J. Yang | EVP And Cco | 8,059 | 08 Jan, 2021 |
| James M Daly | 4,041 | 12 Nov, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Nov, 2025 | Mark C. Schneyer | Common Stock | A | 9,913 | - | 53,687 | D | M |
| 17 Nov, 2025 | James Kihara | Common Stock | A | 3,966 | - | 25,176 | D | M |
| 17 Nov, 2025 | James Kihara | Common Stock | A | 3,966 | - | 29,142 | D | M |
| 17 Nov, 2025 | Mark C. Schneyer | Common Stock | A | 9,913 | - | 63,600 | D | M |
| 18 Nov, 2025 | Mark C. Schneyer | Common Stock | D | 10,262 | $23.69 | 53,338 | D | S |
| 18 Nov, 2025 | James Kihara | Common Stock | D | 4,084 | $23.69 | 25,058 | D | S |
| 10 Nov, 2025 | James M Daly | Common Stock | D | 30,000 | $22.37 | 4,041 | D | S |
| 12 Sep, 2025 | Mark C. Schneyer | Common Stock | A | 6,815 | $0.00 | 46,945 | D | A |
| 15 Sep, 2025 | Mark C. Schneyer | Common Stock | D | 3,498 | $23.65 | 43,447 | D | S |
| 02 Sep, 2025 | Elizabeth A. Garofalo | Common Stock | D | 1,600 | $25.98 | 25,382 | D | S |
| 02 Sep, 2025 | Elizabeth A. Garofalo | - | - | 25,382 | D | |||
| 18 Aug, 2025 | Mark C. Schneyer | Common Stock | D | 22,000 | $25.18 | 40,130 | D | S |
| 04 Jun, 2025 | Laura Brege | Common Stock | D | 14,446 | $21.78 | 15,095 | D | S |
| 29 May, 2025 | Bros. Advisors Lp Baker | Common Stock | A | 16,214 | $0.00 | 3,658,735 | I | A |
| 29 May, 2025 | James M Daly | - | - | 34,041 | D | |||
| 29 May, 2025 | Elizabeth A. Garofalo | Common Stock | A | 9,387 | - | 26,982 | D | M |
| 29 May, 2025 | Laura Brege | Common Stock | A | 9,387 | - | 29,541 | D | M |
| 29 May, 2025 | Adora Ndu | Common Stock | A | 9,387 | - | 24,801 | D | M |
| 29 May, 2025 | Daniel B Soland | Common Stock | A | 9,387 | - | 44,041 | D | M |
| 29 May, 2025 | James M Daly | Common Stock | A | 9,387 | - | 34,041 | D | M |